Bruce Brockstein to Hemangiosarcoma
This is a "connection" page, showing publications Bruce Brockstein has written about Hemangiosarcoma.
Connection Strength
0.215
-
An open-label, multicenter, phase II study of bevacizumab for the treatment of angiosarcoma and epithelioid hemangioendotheliomas. Ann Oncol. 2013 Jan; 24(1):257-63.
Score: 0.106
-
Management of sarcomas of the head and neck. Curr Oncol Rep. 2004 Jul; 6(4):321-7.
Score: 0.060
-
The spectrum of vascular lesions in the mammary skin, including angiosarcoma, after breast conservation treatment for breast cancer. J Am Coll Surg. 2001 Jul; 193(1):22-8.
Score: 0.049